What does PLE stand for?

Buyers chased Plethora Solutions 3p higher to 251/2p.

HEALTH Plethora Solutions says phase two trials for its cystitis and painfulbladder syndrome medicine PSD597 have been positive.

But the company has, in addition, ended its search for a partner for its micelle propofol - another non-core product that uses polymers to effectively deliver an insoluble anaesthetic -and instead has licensed its micelle nanotechnology delivery system to London-based speciality pharmaceutical company Plethora Solutions Holdings who will use it to develop a treatment for interstitial cystitis and painful bladder syndrome.

a Shionogi Company, and Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE), today announced that a second and final Phase III double-blind, placebo-controlled study of PSD502 for the treatment of premature ejaculation ('PE') has met all co-primary endpoints of Intra-vaginal Ejaculation Latency Time ('IELT'), Index of Premature Ejaculation ('IPE,' Ejaculatory Control, Sexual Satisfaction and Distress domains).

Although 2p off at 28p amid talk of a large line of stock overhanging the market, analysts reckon Plethora Solutions could be in for an exciting ride.

a Shionogi Company, today announced that it has acquired the global rights for PSD502 from Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE).

A firm called Plethora Solutions has devised a spray that it reckons can, well, slow things down.

a Shionogi company, and Plethora Solutions Holdings PLC ("Plethora," AIM: PLE), today announced the completion of patient recruitment of the PSD502 registration program for the treatment of premature ejaculation (PE).